Arginyltransferase regulates alpha cardiac actin function, myofibril formation and contractility during heart...

Area of Science:

• Biochemistry
• Developmental Biology
• Cardiovascular Science

Background:

• Post-translational arginylation, mediated by arginyltransferase (Ate1), is vital for mammalian cardiovascular development and angiogenesis.
• Arginylation influences intracellular proteins involved in actin cytoskeleton function and cell motility.
• Previous work highlighted arginylation's role in intracellular processes, but its specific function in cardiac myocyte development remained unclear.

Purpose of the Study:

• To investigate the role of arginylation in the development and function of cardiac myocytes and their actin-based structures during embryogenesis.
• To elucidate the impact of arginylation on the cardiac actin cytoskeleton and myofibril organization.

Main Methods:

• Biochemical analysis and mass spectrometry to identify arginylation sites on cardiac actin.
• Ultrastructural analysis of myofibrils in wild-type and Ate1 knockout mouse hearts.
• Comparison of cardiac myocyte beating patterns from wild-type and knockout embryos.

Main Results:

• Alpha cardiac actin was identified as being arginylated at four sites during development.
• Absence of arginylation in Ate1 knockout mice led to defects in myofibril structure and delayed development.
• Ate1 knockout cardiac myocytes exhibited abnormal beating patterns, indicating impaired contractility and cell-autonomous defects.

Conclusions:

• Arginylation is essential for the proper development and function of cardiac myocytes and their actin cytoskeleton.
• Defects in arginylation lead to structural abnormalities in myofibrils and abnormal cardiac myocyte beating, mimicking human congenital heart diseases.
• This study reveals a novel function for arginylation in regulating the actin cytoskeleton within cardiac myocytes during embryogenesis.